8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields

Bioeffects Seen

Authors not listed · 2010

Share:

Power line frequency EMFs completely blocked melatonin's anti-cancer effects in breast cancer cells at everyday exposure levels.

Plain English Summary

Summary written for general audiences

Researchers exposed breast cancer cells to 50 Hz electromagnetic fields at 1.2 microT (similar to power line levels) for 48 hours and found the EMF completely blocked melatonin's protective anti-cancer effects. Melatonin normally helps suppress breast cancer growth, but the electromagnetic field disrupted the cellular pathways that allow this hormone to work properly.

Why This Matters

This study reveals a deeply concerning mechanism by which power-frequency EMFs may contribute to breast cancer progression. The research demonstrates that even relatively weak magnetic fields - at levels you might encounter near electrical wiring or appliances - can completely disable melatonin's natural tumor-suppressing activity in breast cancer cells. What makes this particularly troubling is that melatonin serves as one of our body's primary defenses against hormone-driven cancers. The 1.2 microT exposure level used in this study is well within the range of everyday environmental exposures, particularly for people living near power lines or working in electrically dense environments. The science demonstrates a clear biological pathway through which chronic EMF exposure could theoretically increase breast cancer risk or interfere with treatment effectiveness. While this was a laboratory study using cell cultures, the molecular mechanisms identified are fundamental to how our bodies naturally fight cancer development.

Exposure Information

A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 50 Hz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 50 HzCell phones~1 GHzWiFi2.4 GHz5G mm28 GHzLogarithmic scale

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2010). Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
Show BibTeX
@article{signal_transduction_of_the_melatonin_receptor_mt1_is_disrupted_in_breast_cancer_cells_by_electromagnetic_fields_ce2154,
  author = {Unknown},
  title = {Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields},
  year = {2010},
  doi = {10.1002/bem.20554},
  
}
DOI: 10.1002/bem.20554PubMed: 19882681

Quick Questions About This Study

Yes, this study found that 50 Hz electromagnetic fields at 1.2 microT completely prevented melatonin from binding to cellular receptors and suppressing breast cancer cell growth, effectively disabling the hormone's natural anti-cancer mechanisms.
The study used 1.2 microT (microtesla) magnetic field strength, which is comparable to levels found near household electrical wiring, some appliances, and areas close to power lines - well within typical environmental exposure ranges.
Yes, the electromagnetic field exposure almost completely eliminated the binding of CREB protein to the BRCA-1 gene promoter, disrupting this important tumor suppressor gene's normal response to melatonin stimulation in breast cancer cells.
The study exposed breast cancer cells to 50 Hz EMF for 48 hours before testing melatonin's effectiveness. This relatively short exposure period was sufficient to completely block the hormone's anti-cancer signaling pathways.
The research showed EMF exposure altered the expression of key cancer-related genes including BRCA-1, p53, p21, and c-myc, preventing melatonin from properly regulating these important tumor suppressor and oncogenes in breast cancer cells.